METREX CAVIWIPES DISINFECTING TOWELETTES CaviWipes 2.0

METREX CAVIWIPES DISINFECTING TOWELETTES CaviWipes 2.0

Regular price $158.00 USD
Sale price $158.00 USD Regular price
SALE Sold out
Shipping calculated at checkout.
Skip to product information
1 of 1

METREX CAVIWIPES DISINFECTING TOWELETTES CaviWipes 2.0

METREX CAVIWIPES DISINFECTING TOWELETTES CaviWipes 2.0

Regular price $158.00 USD
Sale price $158.00 USD Regular price
SALE Sold out
Shipping calculated at checkout.
Packaging
View full details

CaviWipes 2.0

The next-generation CaviWipes 2.0 builds on a decades-long reputation of being trusted by clinicians with strong efficacy claims paramount during times of public health crisis. Fully qualifies for the EPA's rigorous Emerging Viral Pathogen Claim.

  • Proven effective against SARS-CoV-2 on hard non-porous surfaces
  • On EPA List Q*
  • Qualifies for the EPA’s Emerging Viral Pathogens claim for all virus types (enveloped, large and small non-enveloped viruses) to meet current and potentially future infection prevention needs
  • Enhanced Efficacy Claims - Effective against 60 relevant pathogens including Norovirus and Candida auris for added confidence in preventing healthcare associated infections.
  • Excellent Material Compatibility - Compatible with most non-porous, hard surfaces commonly used in clinical settings
  • Easy to use label - Makes it quick and easy to find critical information on efficacy, compatibility, and more
  • 2-minute universal contact time for bacteria, viruses, and pathogenic fungi (Candida auris)

2 Minute Efficacy Against

Non-Enveloped Viruses
  • Adenovirus Type 2
  • Echovirus Type 11
  • Enterovirus Type 71
  • Human Rotavirus
  • Norovirus
  • Adenovirus Type 5
  • Rhinovirus Type 1A
Pathogenic Fungi
  • Candida auris
Multi Drug-Resistant Bacteria
  • Penicillin-Resistant Streptococcus pneumoniae (PRSP)
  • Vancomycin-Resistant Enterococcus faecalis (VRE)
  • Methicillin-Resistant Staphylococcus aureus (MRSA)
  • Carbapenem-resistant Klebsiella pneumoniae (CRKP)
  • Multidrug-Resistant Acinetobacter baumannii (MRAB)
  • NDM-1 Enterobacter cloacae
  • Vancomycin-Intermediate Staphylococcus aureus (VISA)
  • Methicillin-Resistant Staphylococcus epidermidis
  • Multi-Drug Resistant Pseudomonas aeruginosa
  • ESBL Klebsiella pneumoniae
  • ESBL Escherichia coli

 

Bacteria
  • Acinetobacter baumannii
  • Bordetella pertussis
  • Burkholderia cepacia
  • Enterococcus faecium
  • Escherichia coli O157:H7
  • Klebsiella pneumoniae
  • Legionella pneumophila
  • Micrococcus luteus
  • Moraxella catarrhalis
  • Pseudomonas aeruginosa
  • Salmonella enterica
  • Staphylococcus aureus
  • Stenotrophomonas maltophilia
  • Streptococcus mutans
  • Streptococcus pyogenes
  • Klebsiella aerogenes
  • Serratia marcescens
  • Campylobacter jejuni
  • Listeria monocytogenes
  • Shigella dysenteriae
  • Chlamydophila pneumoniae
  • Flavobacterium columnare
  • Mycobacterium tuberculosis (TB)
Enveloped Viruses
  • Herpes simplex virus Type 1
  • Herpes simplex virus Type 2
  • lnfluenza A virus
  • Varicella-zoster virus
  • Cytomegalovirus
  • SARS-associated Coronavirus
  • SARS-CoV-2
  • SARS-CoV-2 – UK Variant
  • SARS-CoV-2 – South African Variant
  • SARs-CoV-2 – California Variant
  • SARS-CoV-2 – Delta Variant
  • lnfluenza B virus
  • Parainfluenza virus Type 3
  • Human orthopneumovirus
  • Measles virus
  • Hepatitis C Virus (HCV)
  • Hepatitis B Virus (HBV)
  • Human lmmunodeficiency Virus Type 1 (HIV-1)
Talk to Us